SEARCH

SEARCH BY CITATION

References

  • Abdel-Hafiz, H., Takimoto, G.S., Tung, L. & Horwitz, K.B. (2002) The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 277, 3395033956.
  • Adams, M., Reginato, M.J., Shao, D., Lazar, M.A. & Chatterjee, V.K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 51285132.
  • Castillo, G., Brun, R.P., Rosenfield, J.K., et al. (1999) An adipogenic cofactor bound by the differentiation domain of PPARγ. EMBO J. 18, 36763687.
  • Chauchereau, A., Amazit, L., Quesne, M., Guiochon-Mantel, A. & Milgrom, E. (2003) Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J. Biol. Chem. 278, 1233512343.
  • David, G., Neptune, M.A. & DePinho, R.A. (2002) SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277, 2365823663.
  • Desterro, J.M., Rodriguez, M.S. & Hay, R.T. (1998) SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2, 233239.
  • Desvergne, B. & Wahli, W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649688.
  • Freiman, R.N. & Tjian, R. (2003) Regulating the regulators: lysine modifications make their mark. Cell 112, 1117.
  • Gelman, L., Zhou, G., Fajas, L., et al. (1999) p300 interacts with the N- and C-terminal part of PPARγ2 in a ligand-independent and -dependent manner, respectively. J. Biol. Chem. 274, 76817688.
  • Gill, G. (2003) Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr. Opin. Genet. Dev. 13, 108113.
  • Girdwood, D., Bumpass, D., Vaughan, O.A., et al. (2003) p300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 10431054.
  • Gong, L., Kamitani, T., Fujise, K., Caskey, L.S. & Yeh, E.T. (1997) Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 272, 2819828201.
  • Hauser, S., Adelmant, G., Sarraf, P., et al. (2000) Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation. J. Biol. Chem. 275, 1852718533.
  • Hi, R., Osada, S., Yumoto, N. & Osumi, T. (1999) Characterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor α. Importance of α-helical structure in the transactivating function. J. Biol. Chem. 274, 3515235158.
  • Hietakangas, V., Ahlskog, J.K., Jakobsson, A.M., et al. (2003) Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23, 29532968.
  • Hirano, Y., Murata, S., Tanaka, K., Shimizu, M. & Sato, R. (2003) Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway. J. Biol. Chem. 278, 1680916819.
  • Hu, E., Kim, J.B., Sarraf, P. & Spiegelman, B.M. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 21002103.
  • Iñiguez-Lluhí, J.A. & Pearce, D. (2000) A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20, 60406050.
  • Kamitani, T., Nguyen, H.P. & Yeh, E.T. (1997) Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272, 1400114004.
  • Kirsh, O., Seeler, J.S., Pichler, A., et al. (2002) The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21, 26822691.
  • Le Drean, Y., Mincheneau, N., Le Goff, P. & Michel, D. (2002) Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143, 34823489.
  • Mangelsdorf, D.J., Thummel, C., Beato, M., et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835839.
  • Miyoshi, H., Blömer, U., Takahashi, M., Gage, F.H. & Verma, I.M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 81508157.
  • Nagai, T., Ibata, K., Park, E.S., et al. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 8790.
  • Ohshima, T., Koga, H. & Shimotohno, K. (2004) Transcriptional activity of peroxisome proliferator-activated receptor γ is modulated by SUMO-1 modification. J. Biol. Chem. 279, 2955129557.
  • Osada, S., Tsukamoto, T., Takiguchi, M., Mori, M. & Osumi, T. (1997) Identification of an extended half-site motif required for the function of peroxisome proliferator-activated receptor α. Genes Cells 2, 315327.
  • Pirkkala, L., Nykänen, P. & Sistonen, L. (2001) Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 15, 11181131.
  • Poukka, H., Karvonen, U., Jänne, O.A. & Palvimo, J.J. (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 97, 1414514150.
  • Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W. & Kahn, C.R. (1998) Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339, 953959.
  • Rodriguez, M.S., Dargemont, C. & Hay, R.T. (2001) SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 1265412659.
  • Ross, S., Best, J.L., Zon, L.I. & Gill, G. (2002) SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10, 831842.
  • Seeler, J.S. & Dejean, A. (2003) Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4, 690699.
  • Shao, D., Rangwala, S.M., Bailey, S.T., et al. (1998) Interdomain communication regulating ligand binding by PPAR-γ. Nature 396, 377380.
  • Shimizu, M., Takeshita, A., Tsukamoto, T., Gonzalez, F.J. & Osumi, T. (2004) Tissue-selective, bidirectional regulation of PEX11α and perilipin genes through a common peroxisome proliferator response element. Mol. Cell. Biol. 24, 13131323.
  • Tallec, L.P., Kirsh, O., Lecomte, M.C., et al. (2003) Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Mol. Endocrinol. 17, 25292542.
  • Tian, S., Poukka, H., Palvimo, J.J. & Jänne, O.A. (2002) Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem. J. 367, 907911.
  • Tominaga, S., Morikawa, M. & Osumi, T. (2002) Growth hormone has dual stage-specific effects on the differentiation of 3T3-L1 preadipocytes. J. Biochem. 132, 881889.
  • Tontonoz, P., Hu, E. & Spiegelman, B.M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 11471156.
  • Verger, A., Perdomo, J. & Crossley, M. (2003) Modification with SUMO. A role in transcriptional regulation. EMBO Report 4, 137142.
  • Werman, A., Hollenberg, A., Solanes, G., et al. (1997) Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). Differential activity of PPARγ1 and -2 isoforms and influence of insulin. J. Biol. Chem. 272, 2023020235.
  • Yamaguchi, T., Dulubova, I., Min, S.W., et al. (2002) Sly1 binds to Golgi and ER syntaxins via a conserved N-terminal peptide motif. Dev. Cell 2, 295305.